COMMUNIQUÉS West-GlobeNewswire

BioSig Engages Consulting Firm for Business Model Strategies

04/04/2024 - 17:35

BAIPC will work to deploy a series of solutions to transform BioSig’s future course Westport, CT, April 04, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical [...]

Lirum Therapeutics to Present Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy Demonstrating Potent Preclinical Activity Against Adult and Pediatric IGF-Related Cancers, at the 2024 AACR Annual Meeting

04/04/2024 - 17:30

New York, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (Lirum), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today the upcoming [...]

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

04/04/2024 - 17:13

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO [...]

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

04/04/2024 - 16:30

RESEARCH TRIANGLE PARK, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Executive Officer Jack Bailey will provide a [...]

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

04/04/2024 - 15:31

HOUSTON, April 04, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and [...]

Allarity Therapeutics Announces 1-for-20 Reverse Stock Split

04/04/2024 - 15:15

Boston (April 4, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the [...]

Benefits Leaders Believe in Power of AI, Considering Data Privacy and Accuracy

04/04/2024 - 15:05

New study indicates that benefits professionals are in an ‘early adopter’ stage with AI DRAPER, Utah, April 04, 2024 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY) ("HealthEquity") released the findings of a new [...]

Study Investigators Conclude RapidPulse™ Precise Cyclic Aspiration Is Highly Effective and Safe for Ischemic Stroke Large Vessel Occlusions

04/04/2024 - 15:04

MIAMI, April 04, 2024 (GLOBE NEWSWIRE) -- A study recently published on-line at Interventional Neuroradiology provided results from a multi-center trial giving promise to the use of precise cyclic aspiration in acute [...]

TerrAscend to Host First Quarter 2024 Earnings Conference Call

04/04/2024 - 15:00

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF) , a leading North American cannabis company, today announced that it will host a scheduled [...]

Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards

04/04/2024 - 15:00

Company recognized by a distinguished industry advisory board for its expertise and leadership in supporting the development of vaccines DURHAM, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s [...]

Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges

04/04/2024 - 15:00

April 4, 2024 Mom & Baby Mobile Health Centers offering ultrasound screenings to expectant moms in Phoenix, Tucson, and Washington, DC Amsterdam, the Netherlands, and Arlington, VA – Philips Foundation , with its [...]

NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.

04/04/2024 - 15:00

EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and [...]

Verana Health Developing Qdata® Dry Eye Disease, the Largest Real-World Dataset of its Kind

04/04/2024 - 15:00

Comprehensive real-world data on more than 10 million patients will help advance research and accelerate therapy development for dry eye disease and other ocular surface disorders SAN FRANCISCO, April 04, 2024 (GLOBE [...]

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

04/04/2024 - 14:59

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges NEW YORK, April 04, [...]

Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024

04/04/2024 - 14:45

Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic [...]

Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth

04/04/2024 - 14:45

2024 Myeloma Action Month Global Campaign Brings Wave of Myeloma Awareness to 36 Countries Worldwide STUDIO CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- At the conclusion of this year’s Myeloma Action Month, the [...]

Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna

04/04/2024 - 14:30

WARMINSTER, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for [...]

eFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined with Pembrolizumab in Non-Small Cell Lung Cancer

04/04/2024 - 14:30

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the [...]

Carmell Announces $3.0 Million Private Placement

04/04/2024 - 14:30

PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced that it [...]